相关实验视频

Updated: Jul 29, 2026

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

2.0K

从中国草药提取物中确定2PHDO作为SOCE抑制剂

Jindou Liu1, Hao Deng2,3,4, Yaxin Li1

  • 1Beijing Key Laboratory of Gene Resource and Molecular Development, College of Life Sciences, Beijing Normal University, Beijing, 100875, China.

Current pharmaceutical biotechnology
|June 15, 2023
PubMed
概括

研究人员发现了2PHDO,一种来自中国草药的新型储存进入抑制剂 (SOCE). 这种化合物有效地阻断了SOCE,并可能作为针对SOCE相关疾病的新疗法的模板.

关键词:
2PHDODO 是一个很好的方法.中国草药医疗法 中医草药医疗法这里是Orai1 .公司 SOCE 公司在STIM1中,抑制剂抑制剂的使用

更多相关视频

Author Spotlight: Integrating 2D-HPLC-MS and Molecular Networking in Natural Medicine Analysis07:50

Author Spotlight: Integrating 2D-HPLC-MS and Molecular Networking in Natural Medicine Analysis

Published on: December 8, 2023

602
Preparation of Gynura bicolor DC samples for High-Resolution Tandem Mass Spectrometry07:16

Preparation of Gynura bicolor DC samples for High-Resolution Tandem Mass Spectrometry

Published on: February 2, 2024

607

相关概念视频

Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...